✦ LIBER ✦

RADIANCE: A Randomized Controlled Study of Ranibizumab in Patients with Choroidal Neovascularization Secondary to Pathologic Myopia

✍ Scribed by Wolf, Sebastian; Balciuniene, Vilma Jurate; Laganovska, Guna; Menchini, Ugo; Ohno-Matsui, Kyoko; Sharma, Tarun; Wong, Tien Y.; Silva, Rufino; Pilz, Stefan; Gekkieva, Margarita

Book ID: 122213298
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 753 KB
Volume: 121
Category: Article
ISSN: 0161-6420
DOI: 10.1016/j.ophtha.2013.10.023

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Choroidal Neovascularization in Patholog

Choroidal Neovascularization in Pathologic Myopia: Intravitreal Ranibizumab Versus Bevacizumab—A Randomized Controlled Trial

✍ Magda Gharbiya; Rosalia Giustolisi; Francesca Allievi; Nicoletta Fantozzi; Luigi 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 579 KB

Circulating hematopoietic stem cells in

Circulating hematopoietic stem cells in patients with choroidal neovascularization secondary to pathologic myopia

✍ Yoshimura, N; Sasahara, M; Otani, A; Yodoi, Y; Gotoh, N; Kameda, T 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 187 KB

Intravitreal ranibizumab in a patient wi

Intravitreal ranibizumab in a patient with choroidal neovascularization secondary to choroidal osteoma

✍ Song, M-h; Roh, Y-j 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 300 KB

Cost-Effectiveness of Ranibizumab for th

Cost-Effectiveness of Ranibizumab for the Treatment of Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia in the United Kingdom

✍ Leteneux, C.; Claxton, L.; Malcolm, W.A.; Taylor, M.; Rathi, H. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Circulating hematopoietic stem cells in

Circulating hematopoietic stem cells in patients with choroidal neovascularisation secondary to pathologic myopia

✍ Sasahara, M; Otani, A; Yodoi, Y; Gotoh, N; Kameda, T; Yoshimura, N 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 88 KB

The Budget Impact of Introducing Ranibiz

The Budget Impact of Introducing Ranibizumab in England and Wales for the Treatment of Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia

✍ Malcolm, W.A.; Leteneux, C.; Claxton, L.; Taylor, M.; Rathi, H. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB